A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndrome.
Mariette X, Barone F, Baldini C, Bootsma H, Clark KL, De Vita S, Gardner DH, Henderson RB, Herdman M, Lerang K, Mistry P, Punwaney R, Seror R, Stone J, van Daele P, van Maurik A, Wisniacki N, Roth DA, Tak PP.
Mariette X, et al.
JCI Insight. 2022 Dec 8;7(23):e163030. doi: 10.1172/jci.insight.163030.
JCI Insight. 2022.
PMID: 36477362
Free PMC article.
Clinical Trial.